Form D · Biotechnology
CytoLogic Inc
Boulder, CO · CIK 0001364357
Offering snapshot reported Jun 15, 2012 · SEC filing
- Reported sold
- $522K Offering amount: $2.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $2.45K Reported outside-investor minimum
- First sale
- Dec 29, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2012 | Initial | $522,073 | No comparison | 8 | SEC filing |
| Dec 13, 2010 | Amendment | $456,564 | $445,924vs Nov 28, 2008 | 14 | SEC filing |
| Nov 28, 2008 | Initial | $10,640 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-179815
Source: Form D, filed Jun 15, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Randy Daughenbaugh | Director |
| Larry M David | Executive |
| Barbara Dusenberry | Director |
| Bernard L Kasten | Director |
| Carol Rae | Director, Executive |
| Dean Stull | Executive |
| Paul Thompson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3133 Indian Road
Boulder, CO, 80301
Boulder, CO, 80301